PerkinElmer will bolster its preclinical portfolio and cell and gene therapy manufacturing capabilities through the acquisition of Nexcelom. PerkinElmer ...
https://www.google.com/url?rct=j&sa=t&url=https://bioprocessintl.com/bioprocess-insider/perkinelmer-set-to-acquire-nexcelom-bioscience-for-260m/&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AFQjCNE8_kx1h0VUhpz9AS-ui6uQ8SWtXQ
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.